Sanofi Q1 Oper Profit Falls 7 Pct, Keeps Targets
PARIS/LONDON (Reuters) - Sanofi-Aventis’s <SASY.PA> sales
and profits fell less than expected in the first quarter but
the French drugmaker said on Wednesday that saredutant, an
experimental antidepressant, had failed in a clinical trial.